16 年
手机商铺
技术资料/正文
15 人阅读发布时间:2026-01-26 14:00
The iCELLis bioreactor technology also provides opportunities for process optimization and simplification that can make the difference between commercial viability and costly process inefficiency.
• Large volume production achieving high cell density and high yield in a small footprint
• Closed, automated operation minimizing risk and maximizing ease of use
• Seed cell densities as low as 3000 cells/cm2 to simplify the seed train demands and streamline the upstream process
• Capable of supporting continuous perfusion processes without modification